The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials
COVID-NMA is an international research initiative supported by the WHO and Cochrane.
For 2023, COVID-NMA revised its protocol and reduced its scope.
- For the living mapping, we continue to update and include all COVID-19 vaccine trials only.
- For the living evidence synthesis, we continue to update only COVID-19 vaccines boosters.
LIVING MAPPING OF TRIALS(i.e., trials registered on Clinicaltrials.gov and EU clinical trials registries
906 RCTs recruiting
LIVING SYNTHESIS OF PUBLISHED STUDIES((include both journals published and preprints)
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis
August 2023: The COVID-NMA living mapping and synthesis has concluded and will no longer be updated.
Living mapping: Last update August 2, 2023. The review is completed and no further update is planned.
Living systematic review Vaccine boosters: Last search date July 30, 2023. No further screening is planned after this date.
Download CSV file (last update: 2023-04-21).
Download CSV file (last update: 2022-09-15).
To receive updates on our project, please subscribe below.